NFA
ENTA icon

Nationwide Fund Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

Nationwide Fund Advisors’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8,892
Closed -$416K – 644
2017
Q3 		$416K Sell
8,892
-347
-4% -$13.9K ﹤0.01% 2272
2017
Q2 		$332K Sell
9,239
-3,071
-25% -$98.2K ﹤0.01% 2391
2017
Q1 		$379K Buy
12,310
+385
+3% +$12K ﹤0.01% 2295
2016
Q4 		$399K Buy
11,925
+1,517
+15% +$43.5K ﹤0.01% 2298
2016
Q3 		$277K Hold
10,408
– – ﹤0.01% 2466
2016
Q2 		$229K Hold
10,408
– – ﹤0.01% 2543
2016
Q1 		$306K Sell
10,408
-85
-0.8% -$2.37K ﹤0.01% 2325
2015
Q4 		$346K Sell
10,493
-8,366
-44% -$273K ﹤0.01% 2292
2015
Q3 		$682K Hold
18,859
– – ﹤0.01% 1923
2015
Q2 		$848K Sell
18,859
-3,795
-17% -$148K ﹤0.01% 1950
2015
Q1 		$694K Buy
22,654
+8,092
+56% +$315K ﹤0.01% 2088
2014
Q4 		$740K Sell
14,562
-26
-0.2% -$1.16K ﹤0.01% 1967
2014
Q3 		$577K Sell
14,588
-45
-0.3% -$1.79K ﹤0.01% 2131
2014
Q2 		$630K Buy
14,633
+3,815
+35% +$146K ﹤0.01% 2132
2014
Q1 		$433K Buy
10,818
+200
+2% +$7.26K ﹤0.01% 2120
2013
Q4 		$290K Sell
10,618
-99
-0.9% -$2.4K ﹤0.01% 2500
2013
Q3 		$246K Buy
10,717
+9,575
+838% +$183K ﹤0.01% 2562
2013
Q2 		$20K Buy
+1,142
New +$22.3K ﹤0.01% 3085

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nationwide Fund Advisors's ENTA Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Enanta Pharmaceuticals (ENTA) in Q4 2017, closing a stake of 8,892 shares — an estimated $416K sold.

Nationwide Fund Advisors first reported a position in ENTA in Q2 2013 and held it in 18 quarters. The position peaked at $848K in Q2 2015. 148 funds tracked by Wall St. Rank hold ENTA as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Enanta Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 8,892 Enanta Pharmaceuticals shares in Q4 2017, an estimated $416K.
  • Nationwide Fund Advisors first reported a position in Enanta Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Enanta Pharmaceuticals position peaked at $848K in Q2 2015.
  • 148 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.